SEARCH RESULTS FOR: "Tag: ACAD"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(2)
2019(1)
2018(6)
2017(5)
2016(13)
2015(10)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(7)
Buzz Stocks(7)
Earnings Preview(1)
General(4)
Intraday Option Activity(6)
Market Recap(2)
Midday Market Check(5)
Opening View(3)
Quantitative Analysis(1)
Stock Market News(2)
Stocks On the Move(6)

8/25/2020 10:38 AM
Acadia Pharmaceuticals Inc (NASDAQ:ACAD) is up 1.15% to trade at $38.40 at last check, after announcing its acquisition of CerSci Therapeutics. The deal will further Acadia's non-opioid pain therapies...
6/29/2020 3:50 PM
The shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) have been trading in a channel of higher highs lately, contained by the $45 and $50 levels during the past three months. The stock has made sev...
11/26/2019 9:32 AM
It's been a huge year for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), thanks to positive updates for its drugs Nuplazid and pimavanserin, the latter of which again has the pharma name in focus. The ...
9/21/2018 9:53 AM
Shares of San Diego-based drug concern ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) are continuing yesterday's surge, with a 6.7% advance to trade at $20.39 out of the gate. Just one day after the Food a...
8/9/2018 10:45 AM
Shares of drug name ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) touched a five-year low of $12.77 out of the gate, but have since turned higher, as traders shrug off an earnings miss. The firm reported...
 
Special Offers from Schaeffer's Trading Partners